表紙:世界の変形性関節症(OA)市場(関節注射、非ステロイド性抗炎症薬/NSAID、鎮痛薬):洞察・動向・予測(2021年~2025年)
市場調査レポート
商品コード
1011012

世界の変形性関節症(OA)市場(関節注射、非ステロイド性抗炎症薬/NSAID、鎮痛薬):洞察・動向・予測(2021年~2025年)

Global Osteoarthritis Market (IA Injections, NSAIDs & Analgesics): Insights, Trends & Forecast (2021-2025)

出版日: | 発行: Koncept Analytics | ページ情報: 英文 122 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.10円
世界の変形性関節症(OA)市場(関節注射、非ステロイド性抗炎症薬/NSAID、鎮痛薬):洞察・動向・予測(2021年~2025年)
出版日: 2021年06月14日
発行: Koncept Analytics
ページ情報: 英文 122 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の変形性関節症(OA)市場の収益は、2021年から2025年にかけて9.85%のCAGRで推移し、2025年までに109億2,000万米ドルに達すると予測されています。変形性関節症の発生率の上昇や、高齢者人口の増加、人口1人当たりの医療費の増加、肥満人口の増加、消費者信頼感指数の改善などの要因によって、当市場の成長が促進される見通しです。いくつかの注目すべき動向には、医薬品の研究開発費の増加や、製品パイプラインの発展、変形性関節症治療の進歩、および医薬品のオンライン販売の増加などが挙げられます。

当レポートでは、世界の変形性関節症(OA)市場について調査し、市場の概要、部位・治療タイプ・流通チャネル・地域別の市場規模の推移と予測、市場の成長要因および課題の分析、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

目次

第1章 市場概要

  • イントロダクション
  • 原因
  • 症状
  • 診断
  • 治療

第2章 世界の変形性関節症(OA)市場の分析

  • 変形性関節症の市場規模
  • 変形性関節症の市場規模の予測
  • 変形性関節症の市場規模:部位別
    • 変形性膝関節症の市場規模
    • 変形性膝関節症の市場規模の予測
    • 変形性膝関節症の市場規模:地域別
  • 変形性関節症の市場規模:治療タイプ別
    • 関節注射(IA)の市場規模
    • 関節注射(IA)の市場規模の予測
    • 治療薬の市場規模
    • 治療薬の市場規模の予測
    • 治療薬の市場規模:タイプ別
    • 非ステロイド性抗炎症薬(NSAIDs)の市場規模
    • 非ステロイド性抗炎症薬(NSAIDs)の市場規模の予測
    • 鎮痛薬の市場規模
    • 鎮痛薬の市場規模の予測
    • 治療薬の市場規模:投与経路別
    • 非経口投与薬の市場規模
    • 非経口投与薬の市場規模の予測
    • 経口投与薬の市場規模
    • 経口投与薬の市場規模の予測
  • 変形性関節症の市場規模:流通チャネル別
  • 変形性関節症の市場規模:地域別

第3章 変形性関節症(OA)市場の分析:地域別

  • 北米
    • 北米の変形性関節症の市場規模
    • 北米の変形性関節症の市場規模の予測
    • 北米の変形性関節症の市場規模:部位別
    • 北米の変形性膝関節症の市場規模
    • 北米の変形性膝関節症の市場規模の予測
    • 北米の変形性膝関節症の市場規模:国別
    • 米国の変形性関節症の市場規模
    • 米国の変形性関節症の市場規模の予測
    • 米国の変形性関節症の市場規模:治療タイプ別
    • 米国の関節注射(IA)の市場規模
    • 米国の関節注射(IA)の市場規模の予測
    • 米国の治療薬の市場規模
    • 米国の治療薬の市場規模の予測
    • 米国の治療薬の市場規模:タイプ別
    • 米国の非ステロイド性抗炎症薬(NSAIDs)の市場規模
    • 米国の非ステロイド性抗炎症薬(NSAIDs)の市場規模の予測
    • 米国の鎮痛薬の市場規模
    • 米国の鎮痛薬の市場規模の予測
  • 欧州
    • 欧州の変形性関節症の市場規模
    • 欧州の変形性関節症の市場規模の予測
    • 欧州の変形性関節症の市場規模:部位別
    • 欧州の変形性膝関節症の市場規模
    • 欧州の変形性膝関節症の市場規模の予測
  • アジア太平洋地域
    • アジア太平洋地域の変形性関節症の市場規模
    • アジア太平洋地域の変形性関節症の市場規模の予測
    • アジア太平洋地域の変形性関節症の市場規模:部位別
    • アジア太平洋地域の変形性膝関節症の市場規模
    • アジア太平洋地域の変形性膝関節症の市場規模の予測

第4章 市場力学

  • 成長要因
    • 変形性関節症の発生率の上昇
    • 高齢者人口の増加
    • 人口1人当たりの医療費の増加
    • 肥満人口の増加
    • 消費者信頼感指数の改善
  • 主な動向と開発
    • 医薬品の研究開発費の伸び
    • 進歩する製品パイプライン
    • 変形性関節症治療の進歩
    • オンライン医薬品販売の成長
  • 課題
    • 関連するビジネスリスク
    • 患者の健康に関連するリスク
    • 厳しい規制

第5章 競合情勢

  • 世界の変形性関節症市場
    • 主要企業の収益の比較
    • 主要企業時価総額の比較
    • 主要企業の研究開発費の比較

第6章 企業プロファイル

  • Johnson & Johnson
  • Novartis AG
  • Bayer AG
  • GlaxoSmithKline Plc
  • Pfizer Inc.
  • Sanofi S.A.
図表

List of Figures

  • Global Osteoarthritis Market Value (2016-2020)
  • Global Osteoarthritis Market Value Forecast (2021-2025)
  • Global Osteoarthritis Market Value by Anatomy Type (2020)
  • Global Knee Osteoarthritis Market Value (2016-2020)
  • Global Knee Osteoarthritis Market Value Forecast (2021-2025)
  • Global Knee Osteoarthritis Market Value by Region (2020)
  • Global Osteoarthritis Market Value by Treatment Type (2020)
  • Global Osteoarthritis IA Injections Market Value (2016-2020)
  • Global Osteoarthritis IA Injections Market Value Forecast (2021-2025)
  • Global Osteoarthritis Drugs Market Value (2016-2020)
  • Global Osteoarthritis Drugs Market Value Forecast (2021-2025)
  • Global Osteoarthritis Drugs Market Value by Type (2020)
  • Global Osteoarthritis NSAIDs Market Value (2016-2020)
  • Global Osteoarthritis NSAIDs Market Value Forecast (2021-2025)
  • Global Osteoarthritis Analgesics Market Value (2016-2020)
  • Global Osteoarthritis Analgesics Market Value Forecast (2021-2025)
  • Global Osteoarthritis Drugs Market Value by Route of Administration (2020)
  • Global Osteoarthritis Parenteral Drugs Market Value (2016-2020)
  • Global Osteoarthritis Parenteral Drugs Market Value Forecast (2021-2025)
  • Global Osteoarthritis Oral Drugs Market Value (2016-2020)
  • Global Osteoarthritis Oral Drugs Market Value Forecast (2021-2025)
  • Global Osteoarthritis Market Value by Distribution Channels (2020)
  • Global Osteoarthritis Market Value by Region (2020)
  • North America Osteoarthritis Market Value (2016-2020)
  • North America Osteoarthritis Market Value Forecast (2021-2025)
  • North America Osteoarthritis Market Value by Anatomy Type (2020)
  • North America Knee Osteoarthritis Market Value (2016-2020)
  • North America Osteoarthritis Market Value Forecast (2021-2025)
  • North America Osteoarthritis Market Value by Country (2020)
  • The U.S. Osteoarthritis Market Value (2016-2020)
  • The U.S. Osteoarthritis Market Value Forecast (2021-2025)
  • The U.S. Osteoarthritis Market Value by Treatment Type (2020)
  • The U.S. Osteoarthritis IA Injections Market Value (2016-2020)
  • The U.S. Osteoarthritis IA Injections Market Value Forecast (2021-2025)
  • The U.S. Osteoarthritis Drugs Market Value (2016-2020)
  • The U.S. Osteoarthritis Drugs Market Value Forecast (2021-2025)
  • The U.S. Osteoarthritis Drugs Market Value by Type (2020)
  • The U.S. Osteoarthritis NSAIDs Market Value (2016-2020)
  • The U.S. Osteoarthritis NSAIDs Market Value Forecast (2021-2025)
  • The U.S. Osteoarthritis Analgesics Market Value (2016-2020)
  • The U.S. Osteoarthritis Analgesics Market Value Forecast (2021-2025)
  • Europe Osteoarthritis Market Value (2016-2020)
  • Europe Osteoarthritis Market Value Forecast (2021-2025)
  • Europe Osteoarthritis Market Value by Anatomy Type (2020)
  • Europe Knee Osteoarthritis Market Value (2016-2020)
  • Europe Knee Osteoarthritis Market Value Forecast (2021-2025)
  • Asia-Pacific Osteoarthritis Market Value (2016-2020)
  • Asia-Pacific Osteoarthritis Market Value Forecast (2021-2025)
  • Asia-Pacific Osteoarthritis Market Value by Anatomy Type (2020)
  • Asia-Pacific Knee Osteoarthritis Market Value (2016-2020)
  • Asia-Pacific Knee Osteoarthritis Market Value Forecast (2021-2025)
  • Global Osteoarthritis Population (2016-2020)
  • Global Geriatric Population (2016-2020)
  • Global Healthcare Expenditure per Capita (2016-2020)
  • The U.S. Obese Population (2016-2020)
  • Consumer Confidence Index in US and Europe (2016-2020)
  • Global Pharmaceutical R&D Expenditures (2016-2020)
  • Global Online Pharmaceutical Sales (2020-2025)
  • Key Players - Market Cap Comparison
  • Key Players - R&D Expenditures Comparison (2019/2020)
  • J&J Sales and Earnings (2016-2020)
  • J&J Sales by Segments (2020)
  • Novartis Net Sales and Net Income (2016-2020)
  • Novartis Net Sales by Segments (2020)
  • Bayer Net Sales and Net Income (Loss) (2016-2020)
  • Bayer Net Sales by Segments (2020)
  • GSK Turnover and Profit (2016-2020)
  • GSK Turnover by Segment (2020)
  • GSK Turnover by Region (2020)
  • Pfizer Revenues and Net Income (2016-2020)
  • Pfizer Revenues by Region (2020)
  • Sanofi Net Sales and Net Income (2016-2020)
  • Sanofi Net Sales by Segments (2020)
  • Sanofi Net Sales by Region (2020)
  • Key Players - Revenues Comparison (2020)
目次

The global osteoarthritis market revenues are forecasted to touch US$10.92 billion in 2025, growing at a CAGR of 9.85% for the period spanning from 2021 to 2025.

Factors such as increasing occurrence of osteoarthritis, growing geriatric population, rising healthcare expenditure per capita, growing obese population and improving consumer confidence index are expected to drive the market growth. However, growth of the industry would be challenged by associated business risk, patient health-associated risk and stringent regulations. A few notable trends include growth in pharmaceutical R&D expenditures, progressing product pipeline, advancement in osteoarthritis treatments and growth in online pharmaceutical sales.

In 2020, the outbreak of COVID-19 pandemic has created an unfavorable impact on the market as the osteoarthritis therapeutics sales declined during Q1-2020.

The global osteoarthritis market by treatment type is segmented into categories i.e. IA Injections (corticosteroids and HA) and Drugs (NSAIDs & Analgesics). Among them, IA injections held the largest share of the industry revenues due to growth in prevalence of joint disorders across the world.

The fastest growing regional market is North America. The growth was supported by growth in geriatric population, surge in HA injections demand, rise in sports injuries and development in e-commerce industry. The U.S. is the largest market and is already well-penetrated at developed market levels

Scope of the report:

  • The report provides a comprehensive analysis of the global osteoarthritis market, segmented into IA Injections and Drugs (Analgesics and NSAIDs).
  • The major regional markets (North America, Europe and Asia-Pacific) have been analysed along with country coverage of US.
  • The market dynamics such as growth drivers, market trends and challenges are analysed in-depth.
  • The competitive landscape of the market, along with the company profiles of leading players i.e. Johnson & Johnson, Novartis AG, Bayer AG, GlaxoSmithKline Plc, Pfizer Inc. and Sanofi S.A. are also presented in detail.

Key Target Audience:

  • Osteoarthritis Therapeutics Manufacturers
  • Ingredient Suppliers
  • End Users
  • Consulting Firms
  • Investment Banks
  • Government Bodies & Regulating Authorities

Table of Contents

1. Market Overview

  • 1.1 Introduction
  • 1.2 Causes
  • 1.3 Symptoms
  • 1.4 Diagnosis
  • 1.5 Treatment

2. Global Osteoarthritis Market Analysis

  • 2.1 Global Osteoarthritis Market Value
  • 2.2 Global Osteoarthritis Market Value Forecast
  • 2.3 Global Osteoarthritis Market Value by Anatomy Type
    • 2.3.1 Global Knee Osteoarthritis Market Value
    • 2.3.2 Global Knee Osteoarthritis Market Value Forecast
    • 2.3.3 Global Knee Osteoarthritis Market Value by Region
  • 2.4 Global Osteoarthritis Market Value by Treatment Type
    • 2.4.1 Global Osteoarthritis IA Injections Market Value
    • 2.4.2 Global Osteoarthritis IA Injections Market Value Forecast
    • 2.4.3 Global Osteoarthritis Drugs Market Value
    • 2.4.4 Global Osteoarthritis Drugs Market Value Forecast
    • 2.4.5 Global Osteoarthritis Drugs Market Value by Type
    • 2.4.6 Global Osteoarthritis NSAIDs Market Value
    • 2.4.7 Global Osteoarthritis NSAIDs Market Value Forecast
    • 2.4.8 Global Osteoarthritis Analgesics Market Value
    • 2.4.9 Global Osteoarthritis Analgesics Market Value Forecast
    • 2.4.10 Global Osteoarthritis Drugs Market Value by Route of Administration
    • 2.4.11 Global Osteoarthritis Parenteral Drugs Market Value
    • 2.4.12 Global Osteoarthritis Parenteral Drugs Market Value Forecast
    • 2.4.13 Global Osteoarthritis Oral Drugs Market Value
    • 2.4.14 Global Osteoarthritis Oral Drugs Market Value Forecast
  • 2.5 Global Osteoarthritis Market Value by Distribution Channels
  • 2.6 Global Osteoarthritis Market Value by Region

3. Regional Osteoarthritis Market Analysis

  • 3.1 North America
    • 3.1.1 North America Osteoarthritis Market Value
    • 3.1.2 North America Osteoarthritis Market Value Forecast
    • 3.1.3 North America Osteoarthritis Market Value by Anatomy Type
    • 3.1.4 North America Knee Osteoarthritis Market Value
    • 3.1.5 North America Knee Osteoarthritis Market Value Forecast
    • 3.1.6 North America Osteoarthritis Market Value by Country
    • 3.1.7 The U.S. Osteoarthritis Market Value
    • 3.1.8 The U.S. Osteoarthritis Market Value Forecast
    • 3.1.9 The U.S. Osteoarthritis Market Value by Treatment Type
    • 3.1.10 The U.S. Osteoarthritis IA Injections Market Value
    • 3.1.11 The U.S. Osteoarthritis IA Injections Market Value Forecast
    • 3.1.12 The U.S. Osteoarthritis Drugs Market Value
    • 3.1.13 The U.S. Osteoarthritis Drugs Market Value Forecast
    • 3.1.14 The U.S. Osteoarthritis Drugs Market Value by Type
    • 3.1.15 The U.S. Osteoarthritis NSAIDs Market Value
    • 3.1.16 The U.S. Osteoarthritis NSAIDs Market Value Forecast
    • 3.1.17 The U.S. Osteoarthritis Analgesics Market Value
    • 3.1.18 The U.S. Osteoarthritis Analgesics Market Value Forecast
  • 3.2 Europe
    • 3.2.1 Europe Osteoarthritis Market Value
    • 3.2.2 Europe Osteoarthritis Market Value Forecast
    • 3.2.3 Europe Osteoarthritis Market Value by Anatomy Type
    • 3.2.4 Europe Knee Osteoarthritis Market Value
    • 3.2.5 Europe Knee Osteoarthritis Market Value Forecast
  • 3.3 Asia-Pacific
    • 3.3.1 Asia-Pacific Osteoarthritis Market Value
    • 3.3.2 Asia-Pacific Osteoarthritis Market Value Forecast
    • 3.3.3 Asia-Pacific Osteoarthritis Market Value by Anatomy Type
    • 3.3.4 Asia-Pacific Knee Osteoarthritis Market Value
    • 3.3.5 Asia-Pacific Knee Osteoarthritis Market Value Forecast

4. Market Dynamics

  • 4.1 Growth Drivers
    • 4.1.1 Inclining Occurrence of Osteoarthritis
    • 4.1.2 Growing Geriatric Population
    • 4.1.3 Rising Healthcare Expenditure per Capita
    • 4.1.4 Growing Obese Population
    • 4.1.5 Improving Consumer Confidence Index
  • 4.2 Key Trends and Developments
    • 4.2.1 Growth in Pharmaceutical R&D Expenditures
    • 4.2.2 Progressing Product Pipeline
    • 4.2.3 Advancement in Osteoarthritis Treatments
    • 4.2.4 Growth in Online Pharmaceutical Sales
  • 4.3 Challenges
    • 4.3.1 Associated Business Risk
    • 4.3.2 Patient Health-Associated Risk
    • 4.3.3 Stringent Regulations

5. Competitive Landscape

  • 5.1 Global Osteoarthritis Market
    • 5.1.1 Key Players - Revenues Comparison
    • 5.1.2 Key Players - Market Cap Comparison
    • 5.1.3 Key Players - R&D Expenditures Comparison

6. Company Profiles

  • 6.1 Johnson & Johnson
    • 6.1.1 Business Overview
    • 6.1.2 Financial Overview
    • 6.1.3 Business Strategies
  • 6.2 Novartis AG
    • 6.2.1 Business Overview
    • 6.2.2 Financial Overview
    • 6.2.3 Business Strategies
  • 6.3 Bayer AG
    • 6.3.1 Business Overview
    • 6.3.2 Financial Overview
    • 6.3.3 Business Strategies
  • 6.4 GlaxoSmithKline Plc
    • 6.4.1 Business Overview
    • 6.4.2 Financial Overview
    • 6.4.3 Business Strategies
  • 6.5 Pfizer Inc.
    • 6.5.1 Business Overview
    • 6.5.2 Financial Overview
    • 6.5.3 Business Strategies
  • 6.6 Sanofi S.A.
    • 6.6.1 Business Overview
    • 6.6.2 Financial Overview
    • 6.6.3 Business Strategies